[Do antenatal @entity288 in term elective cesarean sections reduce XXXX respiratory morbidity?]

@entity1 @entity4837 @entity649 @entity619 @entity63819 @entity288
INTRODUCTION: Neonatal @entity649 is closely related to gestational age and mode of birth. Lowest gestational ages and caesarean section are associated with higher risk of developing @entity649 . The efficacy of antenatal @entity288 is well established in the induction of lung maturation in premature births. Its use could be a beneficial intervention in term fetuses that will be born by elective caesarean section. OBJECTIVE: To find the best evidence available to determine whether the use of antenatal @entity288 reduces the incidence of @entity649 in term babies born by elective caesarean section. METHODOLOGY: We searched the available medical literature in different databases: PubMed, LILACS, UpToDate, @entity63819 database, Scielo and Cochrane. We considered controlled, randomized therapeutic studies, performed on @entity1 , in which the intervention included @entity288 as a treatment in elective term cesareans. RESULTS: We selected two studies. In both, the intervention was two doses of 12 mg of @entity619 before the caesarean section. The primary objective in both studies was to analyze the incidence of @entity649 and the admission of the newborn into intensive care units. In both studies, there was less incidence of @entity4837 @entity649 , with statistically significant results. CONCLUSIONS: We concluded that the use of @entity288 in elective term caesarean section reduces the incidence of @entity4837 @entity649 and the admission into intensive care units. However, we evidenced certain weaknesses that could modify the internal validity of both studies, so it is necessary to develop new studies that could support these findings in order to modify clinical protocols in term elective caesarean sections.
